Biotech
Regulatory
Janssen’s Darzalex (daratumumab) in Combination with Lenalidomide + Dexamethasone Receive
Shots: The approval is based on P-III MAIA study results assessing Darzalex + Lenalidomide + Dexamethasone (Rd) vs Rd as monothx. in 737 newly diagnosed patients with multiple myeloma ineligible […]readmore
